India to Kazakhstan: Leflunomide Export Trade Route
India has recorded 4 verified shipments of Leflunomide exported to Kazakhstan, representing a combined trade value of $119.4K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $29.9K USD. The leading Indian exporter is KUSUM HEALTHCARE PRIVATE LIMITED, which accounts for 100% of total export value with 4 shipments worth $119.4K USD. On the buying side, LLP "DARI-PHARM (KAZAKHSTAN) is the largest importer in Kazakhstan with $68.8K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Kazakhstan Leflunomide corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $119.4K USD. The route is dominated by KUSUM HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's leflunomide manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $29.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with leflunomide's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 33.9%, placing it at rank #16 among India's top leflunomide export destinations globally.
On the import side, key buyers of Indian leflunomide in Kazakhstan include LLP "DARI-PHARM (KAZAKHSTAN), LLP DARI-PHARM KAZAKHSTAN. LLP "DARI-PHARM (KAZAKHSTAN) is the single largest importer with 3 shipments valued at $68.8K USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ4
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#16
- Annual growth+33.9%
- Demand growth+30.0%
- Regulatory ease74/100
Top 10 Indian Leflunomide Exporters to Kazakhstan
Showing top 10 of 1 Indian suppliers exporting Leflunomide to Kazakhstan, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | KUSUM HEALTHCARE PRIVATE LIMITED Avg $29.9K per shipment | 4 | $119.4K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting leflunomide to Kazakhstan, ranked by total trade value. The listed exporters are: KUSUM HEALTHCARE PRIVATE LIMITED. KUSUM HEALTHCARE PRIVATE LIMITED is the dominant supplier with 4 shipments worth $119.4K USD, giving it a 100% market share.
Top 10 Leflunomide Importers in Kazakhstan
Showing top 10 of 2 known buyers in Kazakhstan receiving Leflunomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian leflunomide in Kazakhstan include LLP "DARI-PHARM (KAZAKHSTAN), LLP DARI-PHARM KAZAKHSTAN. The largest importer is LLP "DARI-PHARM (KAZAKHSTAN), accounting for $68.8K USD across 3 shipments — representing 58% of all leflunomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LLP "DARI-PHARM (KAZAKHSTAN) | 3 | $68.8K | 57.6% |
| 2 | LLP DARI-PHARM KAZAKHSTAN | 1 | $50.6K | 42.4% |
Top 10 Leflunomide Formulations Imported by Kazakhstan
Showing top 10 of 4 product formulations shipped on the India to Kazakhstan Leflunomide route, ranked by trade value
Kazakhstan imports a wide range of leflunomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LEFNO-20 TABLETS 3X10S LEFLUNOMIDE 20M — accounts for $50.6K USD across 1 shipments. A total of 4 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LEFNO-20 TABLETS 3X10S LEFLUNOMIDE 20M | 1 | $50.6K | 42.4% |
| 2 | LEFNO-20 TABLETS 3X10S (LEFLUNOMIDE 20MG TABLETS) BATCH NO. 1005776, 1005779, 1005781 DOM- 01.2025 DOE- 12.2027 | 1 | $41.5K | 34.7% |
| 3 | LEFNO-20 TABLETS 3X10S (LEFLUNOMIDE 20MG TABLETS) B/N.1005581 DOM 12.2024 DOE 11.2027 | 1 | $20.4K | 17.1% |
| 4 | LEFNO-20 TABLETS 3X10S (LEFLUNOMIDE 20MG TABLETS) BATCH NO. 1005780 DOM- 01.2025 DOE- 12.2027 | 1 | $6.9K | 5.8% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 2 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's leflunomide exports to Kazakhstan are driven primarily by a handful of large-scale manufacturers. KUSUM HEALTHCARE PRIVATE LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Kazakhstan benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — KUSUM HEALTHCARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $29.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as lefno-20 tablets 3x10s (leflunomide 20mg tablets) batch no. 1005776, 1005779, 1005781 dom- 01.2025 doe- 12.2027 and lefno-20 tablets 3x10s (leflunomide 20mg tablets) b/n.1005581 dom 12.2024 doe 11.2027, suggesting that buyers in Kazakhstan tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, LLP "DARI-PHARM (KAZAKHSTAN) is the largest importer with 3 shipments worth $68.8K USD — representing 58% of all leflunomide imports from India on this route.
Route Statistics
- Trade Volume
- $119.4K
- Avg. Shipment
- $29.9K
- Suppliers
- 1
- Buyers
- 2
- Transit (Sea)
- ~20 days
- Annual Growth
- +33.9%
Related Analysis
Other Leflunomide Routes
Unlock the Full India to Kazakhstan Leflunomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 4 shipments on this route.
Frequently Asked Questions — India to Kazakhstan Leflunomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Leflunomide to Kazakhstan?
The leading Indian exporters of Leflunomide to Kazakhstan are KUSUM HEALTHCARE PRIVATE LIMITED. KUSUM HEALTHCARE PRIVATE LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Leflunomide exports from India to Kazakhstan?
India exports Leflunomide to Kazakhstan worth approximately $119.4K USD across 4 recorded shipments. The average value per shipment is $29.9K USD.
Q Which ports does India use to ship Leflunomide to Kazakhstan?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 2 shipments. Indian exporters primarily use sea freight for this route, with 72% of shipments going by sea and 20% by air.
Q How long does shipping take from India to Kazakhstan for Leflunomide?
The average transit time for Leflunomide shipments from India to Kazakhstan is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Kazakhstan Leflunomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 33.9% with demand growth tracking at 30.0%. The route is ranked #16 among India's top Leflunomide export destinations globally.
Q How many suppliers are active on the India to Kazakhstan Leflunomide route?
There are currently 1 active Indian suppliers exporting Leflunomide to Kazakhstan. The market is moderately concentrated with KUSUM HEALTHCARE PRIVATE LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Leflunomide from India in Kazakhstan?
The leading importers of Indian Leflunomide in Kazakhstan include LLP "DARI-PHARM (KAZAKHSTAN), LLP DARI-PHARM KAZAKHSTAN. LLP "DARI-PHARM (KAZAKHSTAN) is the largest buyer with 3 shipments worth $68.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Kazakhstan export trade corridor identified from Indian Customs (DGFT) records for Leflunomide.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 2 importers in Kazakhstan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 4 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists